Tofacitinib Citrate Intermediates CAS 1062580-52-2

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS 1062580-52-2 appears to be white powder. It can be used as intermediates for Tofacitinib. Tofacitinib CAS 477600-75-2 is an orally available inhibitor of Janus kinases (JAK), with immunomodulatory and anti-inflammatory activities. Upon administration, tofacitinib binds to JAK and prevents the activation of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This may decrease the production of pro-inflammatory cytokines, such as interleukin (IL)-6, -7, -15, -21, interferon-alpha and -beta, and may prevent both an inflammatory response and the inflammation-induced damage caused by certain immunological diseases. JAK kinases are intracellular enzymes involved in signaling pathways affecting hematopoiesis, immunity and inflammation. (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS 1062580-52-2 has a molecular formula of C14H24Cl2N2 and a molecular weight of 291.26. (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS 1062580-52-2 could be supplied in commercial size with competitive price.

Product Details

--2_01.png

Product Description
Name(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride/Tofacitinib Citrate Intermediates CAS 1062580-52-2
Other name

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride ;(3R,4R)-rel-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride ;

cis-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride ;

(3R,4R)-1-Benzyl-N,4-dimethyl-3-piperidinamine dihydrochloride

CAS

1062580-52-2

MF

C14H24Cl2N2

Applications

Tofacitinib intermediate

Appearance

White powder

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS 1062580-52-2 appears to be white powder. It can be used as intermediates for Tofacitinib. Tofacitinib CAS 477600-75-2 is an orally available inhibitor of Janus kinases (JAK), with immunomodulatory and anti-inflammatory activities. Upon administration, tofacitinib binds to JAK and prevents the activation of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This may decrease the production of pro-inflammatory cytokines, such as interleukin (IL)-6, -7, -15, -21, interferon-alpha and -beta, and may prevent both an inflammatory response and the inflammation-induced damage caused by certain immunological diseases. JAK kinases are intracellular enzymes involved in signaling pathways affecting hematopoiesis, immunity and inflammation.

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS 1062580-52-2 has a molecular formula of C14H24Cl2N2 and a molecular weight of 291.26.

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS 1062580-52-2 could be supplied in commercial size with competitive price.

1062580-52-2.jpg


Hot Tags: tofacitinib citrate intermediates cas 1062580-52-2, China, suppliers, manufacturers, factory, wholesale, bulk

Inquiry

You Might Also Like